This program utilizes the power of GLP-1 (glucagon-like peptide-1) medication to shed unwanted pounds
Alongside tirzepatide therapy, adopting a healthy diet, regular exercise, sufficient sleep, and routine check-ins with your provider can optimize your results
Postoperative-ileus and gastric-motility research forms the second major stream and represents the compound's furthest progress through clinical-trial development
All of our products are manufactured in accordance with current Good Manufacturing Practices (cGMP) to ensure the highest standards in quality, safety, and consistency
Tirzepatide (sold under the brand name Mounjaro) is a dual GLP-1 & GIP receptor agonist, making it even more effective for weight loss and metabolic improvement
Specifically, with a dosage of 140 mg every four weeks, the average percentage change in body weight was a decrease of 2.0% on day 7, and by day 78, after three doses, there was an average weight reduction of 7.4%